| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 18 |
| 1 | ADALIMUMAB-AATY | 17 |
| 2 | ADALIMUMAB-ADAZ | 17 |
| 3 | ADALIMUMAB-FKJP | 17 |
| 4 | IPILIMUMAB | 16 |
| 5 | NIVOLUMAB | 16 |
| 6 | ETANERCEPT | 15 |
| 7 | PREDNISONE | 15 |
| 8 | METHOTREXATE SODIUM | 14 |
| 9 | RITUXIMAB | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ECONAZOLE NITRATE | 3 | 0.0032 |
| 1 | CHLORAMBUCIL | 4 | 0.0010 |
| 2 | ATOVAQUONE | 4 | 0.0005 |
| 3 | SUMATRIPTAN SUCCINATE | 11 | 0.0004 |
| 4 | ADALIMUMAB-FKJP | 17 | 0.0004 |
| 5 | IPILIMUMAB | 16 | 0.0004 |
| 6 | ISATUXIMAB | 2 | 0.0003 |
| 7 | ADALIMUMAB-AATY | 17 | 0.0003 |
| 8 | ADALIMUMAB-ADAZ | 17 | 0.0003 |
| 9 | SUMATRIPTAN | 11 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 11 | 0.0004 |
| 1 | Antimalarial [EPC] | 4 | 0.0004 |
| 2 | Antiprotozoal [EPC] | 4 | 0.0004 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 16 | 0.0003 |
| 5 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 17 | 0.0002 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Interleukin-23 Antagonist [EPC] | 11 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |